.svg)
We are a research-driven pharmaceutical company that develops, manufactures and supplies differentiated generic products in the oral solid dosage forms, both as pre-formulation intermediates as well as finished formulations for certain key therapeutic segments. We offer both pharmaceutical and nutraceutical products.
We have in-house R&D capabilities to offer a range of non-infringing drug delivery solutions based on process technologies that enable patient compliance thereby reducing the cost of treatment.
We provide our customers with a comprehensive range of solutions, including product conceptualization, development, BE studies, regulatory support for dossier preparation and submission, product registrations, manufacturing, and supply.
Our offerings encompass differentiated generic products in the form of finished formulations and pre-formulation intermediates, such as granules, pellets (immediate-release, modified-release, delayed-release, etc.), taste-masked powders, dry suspensions, tablets, capsules, and Oral Thin Films (OTF).
ZIM Labs uses its proprietary knowledge, technology and manufacturing process expertise to bridge the technology gap in Regulated, Pharmerging and ROW markets while assisting local players in various geographies to launch differentiated /combination generic products to compete in their respective local markets.
We are innovators in novel drug delivery solutions, leveraging cutting-edge technology to deliver maximum benefits to our clients. Backed by an expert R&D team and state-of-the-art facilities, our vision is to provide niche, affordable, and high-quality healthcare solutions that ensure patient convenience and adherence.
We collaborate with Pharmaceutical and Nutraceutical distribution companies to provide tailored solutions for the development, sourcing, and marketing of differentiated generic products.
We register our products in select markets with plans to enter into marketing tie ups with local distributors and marketing companies for launch of our FF products as branded generics.
Part of FF business, it has been growing steadily over the years on the back of some high value pharmaceutical products and Nutraceutical products.
An independent R&D centre recognized by the DSIR, Govt. of India, has been the originator of differentiated generics based on innovative process technologies. Our manufacturing facilities are EU-GMP, WHO-GMP, ISO 9001 and NSF/ANSI 455-2 certified
We partner with pharmaceutical companies, nutraceutical companies, marketing companies and distributors who seek solutions for product development, brand or product exclusivity extensions, sourcing and marketing of pharmaceutical and nutraceutical products.
